With extensive experience in the field of health economics, IOBE’s Head of the Health Economics Observatory, Thanos Athanasiadis, discusses the background of the organization, the state of the pharmaceutical market in Greece, and the existing challenges and opportunities in the country.
To begin, could you please give an overview of the Foundation for Economic & Industrial Research (IOBE) at large and its main functions? What is the role of the Health Economics Observatory within this organization?
"The prime competitive advantage in [the Greek pharmaceutical sector] is the export capabilities that allows for a strong potential for differentiation."
